Uncategorized
Allergan reports Q3 results, including 90% increase in net revenue
Allergan reported net revenue increasing 90% to $4.1 billion for the quarter ending Sept. 30, compared with $2.2 billion in the third quarter of 2014, according to a press release.“These strong results were driven by our continued focus on customers, fueling volume driven year-over-year growth in our U.S. Brands, Medical Aesthetics, International Brands and Anda Distribution segments, while also executing preintegration activities ahead of the divestiture of the Generics business to Teva, which remains on track to be completed by the first quarter of 2016,” Brent Saunders, CEO and president (Read more...)